Literature DB >> 27474380

What Is the Association of Elite Sporting Activities With the Development of Hip Osteoarthritis?

Jonathan M Vigdorchik1, Jeffrey J Nepple2, Nima Eftekhary1, Michael Leunig3, John C Clohisy2.   

Abstract

BACKGROUND: Male athletes participating in certain elite sporting activities may be at an increased risk for development of hip osteoarthritis (OA) later in life. However, the strength of the association of participation in sporting activities with the increased risk of hip OA has not been well summarized.
PURPOSE: To investigate the association of certain high-impact sporting activities with the risk of development of hip OA in elite athletes by conducting a systematic review of the available literature. STUDY
DESIGN: Systematic review; Level of evidence, 3.
METHODS: PubMed, Cochrane, and EMBASE databases were searched to identify all potential studies. Eleven studies met the inclusion criteria, which included participation in elite-level sporting activities, greater than 50% male athletes in the study population, diagnosis of hip OA by radiograph, hospital admission or total hip arthroplasty (THA), and greater than 80% follow-up. Exclusion criteria were recreational sporting activities, primarily female cohorts as there was a dearth of available literature on the topic, and self-reported symptoms without radiographic confirmation of diagnosis. Most studies were with European athletes, where elite-level was defined as involvement in national- or professional-level competition.
RESULTS: Participation across elite-level impact sports was associated with increased risk of development of hip OA when compared with matched controls (odds ratio, 1.8-8.7). Twelve of 15 studies reviewed demonstrated an odds ratio of 1.8 or greater of developing hip OA in elite-level athletes. Handball was associated with the highest rate of OA of any sport, nearly 5 times that of matched controls. Soccer players demonstrated between 2 and 9 times increased risk of hip OA as defined by radiography or THA. Hockey players demonstrated 2 to 3 times increased risk of hip OA (THA or hospital admission). Five studies investigating the association of competitive long-distance running with hip OA demonstrated inconsistent results.
CONCLUSION: Currently available literature suggests that male athletes participating in elite impact sports (soccer, handball, track and field, or hockey) are at an increased risk of developing hip OA, while those participating in high-level long-distance running do not have a clearly elevated risk. Further research is warranted to elucidate the pathomechanics of development of hip OA in these patients.

Entities:  

Keywords:  arthritis; hip; osteoarthritis; sports

Mesh:

Year:  2016        PMID: 27474380     DOI: 10.1177/0363546516656359

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  14 in total

1.  ESSKA helps making a change: the example of handball medicine.

Authors:  Romain Seil; Lior Laver; Philippe Landreau; Grethe Myklebust; Markus Waldén
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-03-07       Impact factor: 4.342

Review 2.  Epidemiology of osteoarthritis: literature update.

Authors:  Ernest R Vina; C Kent Kwoh
Journal:  Curr Opin Rheumatol       Date:  2018-03       Impact factor: 5.006

3.  Hip arthroscopy is a successful treatment for femoroacetabular impingement in under-16 competitive football players: a prospective study with minimum 2-year follow-up.

Authors:  David Barastegui; Roberto Seijas; Eduard Alentorn-Geli; Alfred Ferré-Aniorte; Patricia Laiz; Ramon Cugat
Journal:  Arch Orthop Trauma Surg       Date:  2022-09-06       Impact factor: 2.928

4.  Do Early-Life Social, Behavioral, and Health Exposures Increase Later-Life Arthritis Incidence?

Authors:  Blakelee R Kemp; Kenneth F Ferraro; Patricia M Morton; Patricia A Thomas; Sarah A Mustillo; Eileen M Crimmins
Journal:  Res Aging       Date:  2021-10-19

5.  Assessing long-term return to play after hip arthroscopy in football players evaluating risk factors for good prognosis.

Authors:  D Barastegui; R Seijas; P Alvarez-Diaz; E Rivera; E Alentorn-Geli; G Steinbacher; X Cuscó; R Cugat
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-05-17       Impact factor: 4.342

6.  An Interpretable Experimental Data Augmentation Method to Improve Knee Health Classification Using Joint Acoustic Emissions.

Authors:  Goktug C Ozmen; Asim H Gazi; Sevda Gharehbaghi; Kristine L Richardson; Mohsen Safaei; Daniel C Whittingslow; Sampath Prahalad; Jennifer L Hunnicutt; John W Xerogeanes; Teresa K Snow; Omer T Inan
Journal:  Ann Biomed Eng       Date:  2021-05-13       Impact factor: 3.934

7.  Return to Sport After Hip Resurfacing Arthroplasty.

Authors:  Kyle W Morse; Ajay Premkumar; Andrew Zhu; Rachelle Morgenstern; Edwin P Su
Journal:  Orthop J Sports Med       Date:  2021-05-06

8.  Endoscopic Shelf Acetabuloplasty for Treating Acetabular Large Bone Cyst in Patient With Dysplasia.

Authors:  Kazuki Yamada; Dean K Matsuda; Hitoshi Suzuki; Akinori Sakai; Soshi Uchida
Journal:  Arthrosc Tech       Date:  2018-06-04

9.  Prevalence of early hip OA features on MRI in high-impact athletes. The femoroacetabular impingement and hip osteoarthritis cohort (FORCe) study.

Authors:  J J Heerey; R Srinivasan; R Agricola; A Smith; J L Kemp; T Pizzari; M G King; P R Lawrenson; M J Scholes; R B Souza; T Link; S Majumdar; K M Crossley
Journal:  Osteoarthritis Cartilage       Date:  2020-12-30       Impact factor: 6.576

10.  Development and formulation of the classification criteria for osteoarthritis.

Authors:  Cibo Huang; Zhiyi Zhang; Yaolong Chen; Yue Zhang; Dan Xing; Like Zhao; Jianhao Lin; Yifang Mei; Hsiao-Yi Lin; Yi Zheng; Wei-Chung Tsai; Shengyun Liu; Quan Jiang; Yi Liu; Jinwei Chen; Zhizhong Ye; Min Chen; Yingjuan Chen; Cong-Qiu Chu; Ming Gao; Lan He; Jin Lin; Lijun Wu; Jianhua Xu; Pinting Yang; Xuewu Zhang; Qing Jiang; Guanghua Lei; Mengtao Li; Wanling Yang; Xin Gu; Yixin Zhou; Dongyi He; Wei Liu; Weiya Zhang; Changhai Ding; Xiaofeng Zeng
Journal:  Ann Transl Med       Date:  2020-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.